C
UTHR icon

Covestor’s United Therapeutics UTHR Stock Holding History

Covestor’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Sell
25
-30
-55% -$16.9K 0.01% 1349
2026
Q1 		$33K Sell
55
-81
-60% -$40.3K 0.02% 925
2025
Q4 		$67K Sell
136
-233
-63% -$109K 0.04% 788
2025
Q3 		$155K Sell
369
-30
-8% -$10.1K 0.09% 323
2025
Q2 		$115K Sell
399
-191
-32% -$57.1K 0.07% 469
2025
Q1 		$182K Sell
590
-16
-3% -$5.48K 0.12% 187
2024
Q4 		$214K Buy
606
+317
+110% +$117K 0.13% 153
2024
Q3 		$103K Sell
289
-176
-38% -$59.5K 0.06% 497
2024
Q2 		$148K Sell
465
-44
-9% -$11.6K 0.1% 283
2024
Q1 		$117K Buy
509
+231
+83% +$52.1K 0.07% 435
2023
Q4 		$61K Sell
278
-534
-66% -$123K 0.04% 760
2023
Q3 		$183K Sell
812
-362
-31% -$83.4K 0.14% 140
2023
Q2 		$259K Buy
1,174
+267
+29% +$59.1K 0.2% 60
2023
Q1 		$203K Buy
907
+15
+2% +$3.7K 0.18% 104
2022
Q4 		$248K Sell
892
-17
-2% -$4.29K 0.2% 67
2022
Q3 		$190K Sell
909
-8
-0.9% -$1.79K 0.17% 92
2022
Q2 		$216K Buy
917
+40
+5% +$8.13K 0.17% 98
2022
Q1 		$157K Buy
877
+572
+188% +$109K 0.1% 254
2021
Q4 		$66K Buy
+305
New +$59.9K 0.09% 374

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Covestor's UTHR Position: Q2 2026 in Review

Covestor reduced its United Therapeutics (UTHR) stake by 55% in Q2 2026, selling an estimated $16.9K and leaving 25 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #1349.

Covestor first reported a position in UTHR in Q4 2021 and has held it in 19 quarters since. The position peaked at $259K in Q2 2023. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Covestor held 25 shares of United Therapeutics worth $14K as of Q2 2026.
  • Covestor sold 30 United Therapeutics shares in Q2 2026, an estimated $16.9K.
  • United Therapeutics made up 0.01% of Covestor's portfolio in Q2 2026, its #1349 holding.
  • Covestor first reported a position in United Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Covestor's United Therapeutics position peaked at $259K in Q2 2023.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.